Modified exendins and exendin agonists
First Claim
Patent Images
1. A pharmaceutical composition comprising (1) a pharmaceutically acceptable carrier and (2) a PEGylated peptide comprising the amino acid sequence of SEQ ID NO:
- 211, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 236, 239, or 240.
3 Assignments
0 Petitions
Accused Products
Abstract
Novel modified exendins and exendin agonists having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, and related formulations and dosages and methods of administration thereof are provided. These modified exendins and exendin agonists, compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
74 Citations
25 Claims
-
1. A pharmaceutical composition comprising (1) a pharmaceutically acceptable carrier and (2) a PEGylated peptide comprising the amino acid sequence of SEQ ID NO:
- 211, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 236, 239, or 240.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
Specification